IMMIX BIOPHARMA, INC. (IMMX)

Every figure this model derived for IMMX, the value it took, and the element in the company's own XBRL it was read from — so any of it can be checked against the filing rather than taken on trust.

The figures, and where each came from

This is the part no other screener shows. Each figure below names the XBRL element it was read from, so it can be checked against the filing itself.

FigureValueXBRL tagAs at
capex 591,111 PaymentsToAcquirePropertyPlantAndEquipment 2026-06-30
cash 232,107,153 CashAndCashEquivalentsAtCarryingValue 2026-06-30
current assets 233,790,071 AssetsCurrent 2026-06-30
current liabilities 9,301,705 LiabilitiesCurrent 2026-06-30
equity 228,916,553 StockholdersEquity 2026-06-30
interest expense 497 InterestExpense 2022-12-31
ocf -38,498,081 NetCashProvidedByUsedInOperatingActivities 2026-06-30
sbc 2,594,972 ShareBasedCompensation 2026-06-30

The ratios

The figures themselves rather than their scores — what somebody looking up IMMX on one particular measure came for.

RatioValue
current ratio25.13
current ratio reported25.13
dilution pct16.56
interest cover-84136.79

What to be careful about

What this model itself distrusts about IMMX's figures. Written by the derivation as it ran, not added afterwards.